Literature DB >> 3198765

Determinants of hepatic function in liver cirrhosis in the rat. Multivariate analysis.

J Reichen1, B Egger, N Ohara, T B Zeltner, T Zysset, A Zimmermann.   

Abstract

We investigated the determinants of hepatic clearance functions in a rat model of liver cirrhosis induced by phenobarbital/CCl4. Aminopyrine N-demethylation (ABT), galactose elimination (GBT), and serum bile acids (SBA) were determined in vivo. The livers were then characterized hemodynamically: intrahepatic shunting (IHS) was determined by microspheres and sinusoidal capillarization by measuring the extravascular albumin space (EVA) by a multiple indicator dilution technique. The intrinsic clearance was determined by assaying the activity of the rate-limiting enzymes in vitro. Hepatocellular volume (HCV) was measured by morphometry. ABT and SBA, but not GBT, differentiated cirrhotic from normal liver. IHS ranged from normal to 10%; all cirrhotic livers showed evidence of sinusoidal capillarization (reduced EVA). The cirrhotic livers showed a bimodal distribution of HCV, HCV being decreased in 50% of the cirrhotic livers. Multivariate analysis showed EVA and portal flow to be the main determinants of microsomal (ABT) and cytosolic (GBT) clearance function; SBA, by contrast, were determined solely by IHS. We conclude that sinusoidal capillarization is the main determinant of hepatic clearance, while serum bile acids reflect intrahepatic shunting. These findings emphasize the importance of alterations of hepatic nutritional flow to explain reduced clearance function in cirrhosis of the liver.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3198765      PMCID: PMC442790          DOI: 10.1172/JCI113828

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

1.  Determination of the hepatic galactose elimination capacity after a single intravenous injection in man: the reproducibility and the influence of uneven distribution.

Authors:  N TYGSTRUP
Journal:  Acta Physiol Scand       Date:  1963 Jun-Jul

2.  Preoperative liver function tests correlated with encephalopathy after porta-caval anastomosis.

Authors:  T Kardel; K Ramsöe; S Nörby Rasmussen
Journal:  Scand J Gastroenterol       Date:  1975       Impact factor: 2.423

3.  Quantitation of portasystemic shunting from the splenic and mesenteric beds in alcoholic liver disease.

Authors:  R Groszmann; B Kotelanski; J N Cohn; I M Khatri
Journal:  Am J Med       Date:  1972-12       Impact factor: 4.965

4.  Criteria for assessment of functional impairment in patients with cirrhosis of the liver.

Authors:  J Bircher; R Blankart; A Halpern; W Häcki; J Laissue; R Preisig
Journal:  Eur J Clin Invest       Date:  1973-01       Impact factor: 4.686

5.  Clearance concepts in pharmacokinetics.

Authors:  M Rowland; L Z Benet; G G Graham
Journal:  J Pharmacokinet Biopharm       Date:  1973-04

6.  Instant cirrhosis. An improved method for producing cirrhosis of the liver in rats by simultaneous administration of carbon tetrachloride and phenobarbitone.

Authors:  E K McLean; A E McLean; P M Sutton
Journal:  Br J Exp Pathol       Date:  1969-10

7.  Expiratory measurement of maximal amino-pyrine demethylation in vivo: effect of phenobarbital, partial hepatectomy, protacaval shunt and bile duct ligation in the rat.

Authors:  B H Lauterburg; J Bircher
Journal:  J Pharmacol Exp Ther       Date:  1976-02       Impact factor: 4.030

8.  The effects of age and liver disease on the disposition and elimination of diazepam in adult man.

Authors:  U Klotz; G R Avant; A Hoyumpa; S Schenker; G R Wilkinson
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

9.  On the uptake of materials by the intact liver. The transport and net removal of galactose.

Authors:  C A Goresky; G G Bach; B E Nadeau
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

10.  Test for alcoholic cirrhosis by conversion of [14C]- or [13C]galactose to expired CO2.

Authors:  W W Shreeve; J D Shoop; D G Ott; B B McInteer
Journal:  Gastroenterology       Date:  1976-07       Impact factor: 22.682

View more
  18 in total

Review 1.  Clinical pharmacokinetics in patients with liver disease.

Authors:  A J McLean; D J Morgan
Journal:  Clin Pharmacokinet       Date:  1991-07       Impact factor: 6.447

2.  Preoperative galactose elimination capacity predicts complications and survival after hepatic resection.

Authors:  Claudio A Redaelli; Jean-François Dufour; Markus Wagner; Martin Schilling; Jürg Hüsler; Lukas Krähenbühl; Markus W Büchler; Jürg Reichen
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

3.  Assessment of the hepatic microvascular changes in liver cirrhosis by perfusion computed tomography.

Authors:  Mai-Lin Chen; Qing-Yu Zeng; Jian-Wei Huo; Xiao-Ming Yin; Bao-Ping Li; Jian-Xin Liu
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

4.  Hepatic fibrosis: evaluation with semiquantitative contrast-enhanced CT.

Authors:  Vanja Varenika; Yanjun Fu; Jacquelyn J Maher; Dongwei Gao; Sanjay Kakar; Miguel C Cabarrus; Benjamin M Yeh
Journal:  Radiology       Date:  2012-11-20       Impact factor: 11.105

5.  Effect of insufflation gas and intraabdominal pressure on portal venous flow during pneumoperitoneum in the rat.

Authors:  T C Schmandra; Z G Kim; C N Gutt
Journal:  Surg Endosc       Date:  2000-12-12       Impact factor: 4.584

6.  CT evaluations of focal liver reactions following stereotactic body radiotherapy for small hepatocellular carcinoma with cirrhosis: relationship between imaging appearance and baseline liver function.

Authors:  N Sanuki-Fujimoto; A Takeda; T Ohashi; E Kunieda; S Iwabuchi; K Takatsuka; N Koike; N Shigematsu
Journal:  Br J Radiol       Date:  2010-12       Impact factor: 3.039

7.  Pharmacokinetics and haemodynamic effects of a single oral dose of the novel ACE inhibitor spirapril in patients with chronic liver disease.

Authors:  S Krähenbühl; P Grass; A Surve; K Kutz; J Reichen
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  The influence of old age and poloxamer-407 on the hepatic disposition of diazepam in the isolated perfused rat liver.

Authors:  Sarah J Mitchell; Aniko Huizer-Pajkos; Victoria C Cogger; Andrew J McLachlan; David G Le Couteur; Brett Jones; Rafael de Cabo; Sarah N Hilmer
Journal:  Pharmacology       Date:  2012-09-19       Impact factor: 2.547

Review 9.  Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update.

Authors:  D J Morgan; A J McLean
Journal:  Clin Pharmacokinet       Date:  1995-11       Impact factor: 6.447

10.  Propranolol ameliorates the development of portal-systemic shunting in a chronic murine schistosomiasis model of portal hypertension.

Authors:  S K Sarin; R J Groszmann; P G Mosca; M Rojkind; M J Stadecker; R Bhatnagar; A Reuben; Y Dayal
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.